Smart State Strategy: The Queensland Life Sciences Success Story The Honourable Peter Beattie

1
Smart State Strategy The Queensland Life
Sciences Success Story The Honourable
Peter Beattie
2
Queensland, Australia

• Economic outlook strong growth prospects
• Smart State vision investing in knowledge
• Education Reforms
• Fostering knowledge sectors
• Biotechnology Strategic Plan
• Approach
• Strengths
• Initiatives
• Smart State Future Directions

3
Queenslands economic outlook

• AAA credit rating
• Economic growth of 4.25 for 2008/09
• Unemployment rate of 3.6 (4.2 nationally)
• Population growth double the national average
• Around 18.8 of Australian GDP in 2006/07
• 134 billion in total major investment projects
• Strong investment across sectors (37.2 billion
  in projects under construction in December 2007)

Gross State Product by Industry
4
Queensland the Smart State

• Vision an economy where by 2025, knowledge
  based industries account for 50 of all business
  activity across Queensland

Institute for Molecular Biosciences, University
of Queensland
5
Achieving the vision
6
Education

• Higher levels of education and training
• Since 2002 significant reforms to education and
  vocational education and training systems
• Major changes to the schools curriculum
• 1 billion Queensland Skills Plan steering
  Queenslands VET system

7
Research

• Queenslands expanding research capacity is
  creating the ideas on which Queenslanders can
  strengthen the States current industries and
  build new ones.
• The Queensland Government is
• Investing in world class research infrastructure
  in collaboration with higher education and
  private organisations.
• Facilitating the exchange of ideas between the
  research community.
• Supporting the development of Queensland research
  base by targeting human capital.

8
Innovation

• Queensland solid research and science base is
  enabling industry and higher education to
  maximise opportunities to commercialise new
  ideas.
• Three key objectives
• Encouraging business to drive innovation through
  research and development
• Promoting the commercialisation of new
  knowledge
• Supporting the emergence of new, knowledge and
  technology-intensive sectors.

9
Smart State Sectors

• Sectoral action plans have been developed to
  promote the growth of Smart Sectors
• information and communication technology (ICT)
• business services
• food and agribusiness
• aviation and aerospace
• marine industries
• environmental services and technologies
• creative industries
• advanced manufacturing
• business events
• clean coal technology
• biotechnology, pharmaceuticals and nutraceuticals

10
Smart State Fostering Knowledge Industries

• Biotechnology
• Industry grown 4-fold in past 10 years
• Over 1.6 B invested in Queensland Health and
  Medical research facilities
• Around 90 companies focused on commercialising IP
• Over 4,000 skilled jobs created
• 23 drugs/products in clinical development

11
Queenslands biotechnology strategy

• Vision for Industry
• Strategic Investments
• Over 650 million invested in biotechnology

By 2025 - employing over 16,000 people -
generating AUD4 billion in revenue - AUD20
billion industry
12
An integrated approach
13
Biotech areas of competitive strength

• Health and Medical
• Tropical Agricultural Biotechnology
• Industrial and Environmental Biotechnology

14
Biotech RD - infrastructure

• Queensland Government has invested 0.6 billion
  in health and medical RD, which leveraged over
  1 billion from other sources.
• Queensland Institute of Medical Research
• Institute for Molecular Biosciences
• Queensland Brain Institute
• Mater Medical Research Institute
• Diamantina Institute for Cancer, Immunology and
  Metabolic Medicine
• Institute of Health and Biomedical Innovation
• Institute for Glycomics
• Australian Institute for Bioengineering and
  Nanotechnology
• Eskitis Institute for Cell and Molecular
  Therapies
• Wesley Research Institute

Australian Institute for Bioengineering and
Nanotechnology
15
Building a track record

• Worlds first cervical cancer vaccine discovered
  in Queensland
• Peplin Ltd Phase II trials for skin cancer
  compound
• Alchemia Ltd Phase II trials for metastatic
  colorectal cancer treatment, phase III trial
  pending
• Implicit Bioscience Phase II trials for immune
  response regulator against hepatitis C

Professor Ian Frazer discovered the worlds first
cervical cancer vaccine now distributed as
Gardasil by Merck in the US and CSL in Australia
16
Future directions

• Leveraging science investment and mandating
  collaboration
• Early stage commercialisation (i.Lab and
  teQstart)
• Smart Therapies Institute (TRI and BPA)
• Queensland Clinical Trials Network
• Key international alliances North America
  (South Carolina, Washington State, British
  Columbia)
• Regulatory frameworks Gene Technology, Stem
  Cells, Biodiscovery

17
Early stage commercialisation

• i.lab
• Since its establishment in 2000, i.lab has been
  home to over 87 start-up companies, creating more
  than 350 technology jobs and raising over 55
  million in investment capital
• teQstart
• Since establishment in 2003 teQstart has assisted
  27 start-up companies by investing funds on a
  co-investment basis
• Investments of 6 million have leveraged a
  further 80 million across the portfolio from the
  private sector, equating to an average leverage
  rate of 14 to 1

18
Queensland Clinical Trials Network (QCTN)

• Association of members over 50 preclinical and
  clinical trial providers
• Markets and promotes Queenslands capabilities
  and provides a visible point of contact
• Queensland Government funding of 5M over four
  years (2004-2008)
• Key achievements include
• Doubling of preclinical and clinical trials
  revenue growth for members
• Total number of Members employees grew by 235
• Signing of four MoU/SOIs with international
  organisations
• Business contacts generated 3538 leads since
  2005
• Direct financial returns to members

19
Commercial results of international collaboration
and exposure

• Catapult Genetics Pty Ltd, recently acquired by
  Pfizer Animal Health
• Panbio Ltd, recently acquired by Inverness
  Medical Innovations now a global exporter of
  innovative diagnostics for over 30 infectious
  diseases
• Syngenta partnered with Farmacule and QUT to
  develop cellulosic ethanol and biofuels derived
  from sugarcane
• Sanofi-aventis has completed its 560 million
  acquisition of the Symbion consumer business that
  makes and distributes vitamins and mineral
  supplements

20
Future directions Smart State Strategy 2008-2012

• Smart State Phase 3 moving from bricks to
  brains
• Focusing investment in people, ideas and
  partnerships
• New Smart State Fellowships
• Health and Medical Research Program (25 million)
• Skills Fund (23.3 million)
• Project Fund (60 million)
• New Proof-of-Concept fund (4 million)
• Investment Ready Program (2 million)

21
Future - Smart Communities

• Aligning Government expenditure and
  infrastructure with RD
• Consolidate leverage existing assets
• Concentrate stimulate research collaboration
• Attract retain industry, knowledge workers and
  entrepreneurs
• Enhance innovation competitiveness
• Build competitive advantage
• Leverage Government infrastructure investment
• Create critical mass
• Deliver greater prosperity quality of life

22
Future - Smart Therapies Institute

• Translational Research
• 320M translational research facility
• Joint collaborative venture
• Combining the talents of Prof Ian Frazer with
  Prof Derek Hart
• To be completed late 2011, housing 600
  researchers
• It will be the first Institute of its kind in
  Australia - and one of only a few in the world

Interior of the Translational Research Institute
(artists impression)
23
Smart Therapies Institute
24
Future - Smart Therapies Institute

• BioPharmaceuticals Australia
• Co-locating with the TRI
• 50m total funding secured
• Network of local complementary service providers
  supporting the new facility
• Poised to become the preferred Contract
  Manufacturing Organization nation wide, competing
  internationally.
• Construction commencing 2009 with commercial
  operation anticipated 2012

Members of BPAs Design Review Team at the AIBN
25
(No Transcript)
26
Biodiscovery

• Queensland is Australias most naturally diverse
  state
• Strong track record in early stage biodiscovery
• First jurisdiction in Australia to introduce
  worlds best-practice biodiscovery legislation to
  create legal certainty for those undertaking
  biodiscovery activities
• The Biodiscovery Act 2004 (Qld) provides
  streamlined, sustainable access to the States
  native biological resources whilst returning a
  fair and equitable benefit to the community

27
Quality of life
28
Quality of life
29
Contacts

• Queensland Government Office the Americas
• 350 S Grand Avenue
• Los Angeles CA 90071
• Phone [phone]
• Website www.biotech.qld.gov.au